Piotr Wilkowski

Piotr Wilkowski

Auto-generated profile, based on publicly available information

Piotr Wilkowski

Department of Immunology, Transplant Medicine and Internal Diseases, Medical University of Warsaw, Warsaw, Poland

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Transplantation Proceedings
Verified
Journal Article
Closed access
PWP. Wilkowski
P. Wilkowski
MCMichał Ciszek
Michał Ciszek
KDK. Dobrzaniecka
K. Dobrzaniecka
JSJ. Sańko-Resmer
J. Sańko-Resmer
AŁA. Łabuś
A. Łabuś
LPLeszek Pączek
Leszek Pączek

1 July 2018 in Transplantation Proceedings
Verified
Journal Article
Closed access
PWP. Wilkowski
P. Wilkowski
KGK. Gajko
K. Gajko
MMM. Marczak
M. Marczak
EHE. Hryniewiecka
E. Hryniewiecka
MWM. Wojtowicz
M. Wojtowicz
MCMichał Ciszek
Michał Ciszek

1 September 2018 in Transplantation Proceedings
Verified
Journal Article
Closed access
MWM. Wojtowicz
M. Wojtowicz
PWP. Wilkowski
P. Wilkowski
EHE. Hryniewiecka
E. Hryniewiecka
TCT. Cieciura
T. Cieciura
LPLeszek Pączek
Leszek Pączek
MCM. Ciszek
M. Ciszek

28 October 2017 in Jundishapur Journal of Microbiology
Verified
Journal Article
Open access
PDF file
PWPiotr Wilkowski
Piotr Wilkowski
MCMichał Ciszek
Michał Ciszek
KDKornelia Dobrzaniecka
Kornelia Dobrzaniecka
MWMonika Wojtowicz
Monika Wojtowicz
DWDariusz Wasiak
Dariusz Wasiak
LPLeszek Pączek
Leszek Pączek
Introduction: An increase in the number of infections with Klebsiella pneumoniae producing Extended-Spectrum β-Lactamase (ESBL+) is a clinical issue, because there are no guidelines regarding the correct choice of an antibiotic and duration of treatment in kidney transplant recipients. The bacterial capacity to degrade almost all β-lactam antibiotics, except carbapenems, causes resistance to standard treatment and makes long-term intravenous antibiotic therapy necessary. Case Presentation: This report describes the case of a 44-year-old patient after kidney transplantation, who developed recurrent urinary tract infections (UTIs) caused by ESBL-producing K. pneumoniae despite prolonged antibiotic targeted treatments with imipenem/cilastatin, meropenem, imipenem/cilastatin with amikacin and oral phosphomycin for UTI prophylaxis. Ineffectiveness of previous treatments caused the necessity to use a non-standard therapy of the consecutive UTI episode with high doses of amoxicillin combined with standard doses of clavulanic acid to break the bacteria’s resistance. There was no recurrence of UTI and control urine cultures were sterile over the entire course of treatment, lasting 165 days, and throughout the follow-up period of more than 1 year. Conclusions: It has been shown in this case that UTI with the aetiology of K. pneumoniae could be treated on an outpatient basis with high doses of amoxicillin in combination with standard doses of clavulanic acid followed by prolonged antibiotic prophylaxis. Keywords: Amoxicillin; Clavulanic Acid; Drug Resistance, Bacterial; Beta-Lactamases, Urinary Tract Infections; Kidney Transplantation; Klebsiella pneumoniae; Klebsiella Infections